Fig. 2From: Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trialPeripheral Blood Collection Timeline. SOC = standard of care; SABR = stereotactic ablative radiotherapy. Study completion is defined as 5 years of follow-up. Samples will include 2 vials of blood for circulating tumor DNA and peripheral blood mononuclear cell isolationBack to article page